Search - tctmd.com

Displaying 201 - 218 of 218

Sort: Relevancy | Date

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Industry News

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

July 11, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Jason Kahn

May 12, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

News Daily News

Insurance Type Affects Outcomes After PCI

L.A. McKeown

January 06, 2011

CME

Advertisement

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Medtronic Starts Landmark Study of Hypertension Treatment

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Poor Association Between Stent Thrombosis, Platelet Function Tests

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Cilostazol Reduces Repeat Revascularizations for Long Lesions

GPIs in Elective PCI: Older Drugs Still Have a Role

Insurance Type Affects Outcomes After PCI

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content